Latest news
Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update - Business WireBusiness Wire · Wed, 05 Aug 2026 20:01:00 GMTClinilabs Announces Medical Leadership Appointments - NTB KommunikasjonNTB Kommunikasjon · Wed, 05 Aug 2026 14:05:00 GMTTravere Therapeutics Reports Second Quarter 2026 Financial Results - Business WireBusiness Wire · Tue, 04 Aug 2026 20:01:00 GMTRocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease - Business WireBusiness Wire · Mon, 03 Aug 2026 11:00:00 GMT